Bio-Raid
CAR-T technology

CAR-T technology

Currently, CAR T immune cell therapy technologies, including CD19, CD20, CD22, CD30, CD33, BCMA and HIV
CAR-T technology

CAR-T technology

Currently, CAR T immune cell therapy technologies, including CD19, CD20, CD22, CD30, CD33, BCMA and HIV
China Voice on ASCO: The latest clinical progress of various cell therapy companies,CARsgen,Bio-Raid, PREGENE, and EUREKA... Original:Wanyi Chen Medical Mace eMedClub 1 week ago
03 2019-07

China Voice on ASCO: The latest clinical progress of various cell therapy companies,CARsgen,Bio-Raid, PREGENE, and EUREKA... Original:Wanyi Chen Medical Mace eMedClub 1 week ago

This article is original by Medical Mace eMedClub, welcome to share, reprint must be authorized May 21, 2019 / Medical Mace eMedClub / -Local May 31 to June 4, the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois, USA Held.
More
Academician Carl H. June, one of the founders of CAR-T Cell Therapy, officially signed the "Chief Scientist" of Bio-Raid!
28 2019-03

Academician Carl H. June, one of the founders of CAR-T Cell Therapy, officially signed the "Chief Scientist" of Bio-Raid!

Mar.28th. " Wuhan Bio-Raid - American academician workstation opening ceremony " was held at the Bio-Raid Co.,Ltd. Carl H. June , one of the founders of CAR-T Cell Therapy, the most influential scientist in the global biopharmaceutical industry and a tenured professor of the Perelman School of Medicine at the University of Pennsylvania, was hired as the company's " chief scientist " and authorized in Bio-Raid. established "Academician Workstation". Academician Carl H. June , Tongcun Zhang, Chairman of Bio-Raid, Feng Li, Chief Engineer of Wuhan Donghu New Technology Development Zone Management Committee, and Gao Shangwei, Vice President of Wuhan Biotechnology Research Institute , unveiled the "Academician Workstation".
More
Chen Anli, deputy governor of Hubei Province, praised Porida Bio Company
10 2019-01

Chen Anli, deputy governor of Hubei Province, praised Porida Bio Company

In the morning of January 9, Anli Chen ,Vice Governor of Hubei Province visited our company and gave a high evaluation to company’s achievements made in cancer treatment. Linzhang Wu, deputy director of the Provincial Department of Science and Technology, Li Feng, chief engineer of the Donghu High-tech Zone Management Committee, Jianyi Kong, secretary of the Party Committee of Wuhan University of Science and Technology, and Hongwei Ni, president of the University of Science and Technology accompanyed inspection.
More

Technical

CAR T, a hematologic tumor, has been targeted at many mature targets such as CD30,CD19,CD22,CD99,CD20,MMSA-1 and BCMA for leukemia, lymphoma and multiple myeloma. At present, more than 400 clinical trials and studies have been completed with exciting efficacy.

Bio-Raid

a1

Time of issue:2019-06-28 00:00:00
无标题文档

Overview

a2

Time of issue:2019-06-28 00:00:00

Technology

a3

Time of issue:2019-06-28 00:00:00

Pipeline

a4

Time of issue:2019-06-28 00:00:00

Paper
这是描述信息
New Hope, New Journey – Wuhan Bio-Raid Biotechnology Co.,Ltd Hosts New Employee Meeting

2019

06-12

New Hope, New Journey – Wuhan Bio-Raid Biotechnology Co.,Ltd Hosts New Employee Meeting
On June 5, Wuhan Bio-Raid Biotechnology Co., Ltd. held a meeting of new employees in 2019.The chairman of the company attended the meeting and held face-to-face discussions with the new employees.
China Voice on ASCO: The latest clinical progress of various cell therapy companies,CARsgen,Bio-Raid, PREGENE, and EUREKA... Original:Wanyi Chen Medical Mace eMedClub 1 week ago

2019

07-03

China Voice on ASCO: The latest clinical progress of various cell therapy companies,CARsgen,Bio-Raid, PREGENE, and EUREKA... Original:Wanyi Chen Medical Mace eMedClub 1 week ago
This article is original by Medical Mace eMedClub, welcome to share, reprint must be authorized May 21, 2019 / Medical Mace eMedClub / -Local May 31 to June 4, the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois, USA Held.
China urged to abandon plan to sell unproven cell therapies

2019

03-01

China urged to abandon plan to sell unproven cell therapies
An international stem-cell body says the country’s proposed law could put patients at risk. An international group of stem-cell researchers is urging China to cancel draft regulations that would permi

2019

03-28

Academician Carl H. June, one of the founders of CAR-T Cell Therapy, officially signed the "Chief Scientist" of Bio-Raid!

Mar.28th. " Wuhan Bio-Raid - American academician workstation opening ceremony " was held at the Bio-Raid Co.,Ltd. Carl H. June , one of the founders of CAR-T Cell Therapy, the most influential scientist in the global biopharmaceutical industry and a tenured professor of the Perelman School of Medicine at the University of Pennsylvania, was hired as the company's " chief scientist " and authorized in Bio-Raid. established "Academician Workstation". Academician Carl H. June , Tongcun Zhang, Chairman of Bio-Raid, Feng Li, Chief Engineer of Wuhan Donghu New Technology Development Zone Management Committee, and Gao Shangwei, Vice President of Wuhan Biotechnology Research Institute , unveiled the "Academician Workstation".

2019

02-25

Provincial Department of Organizational Department special investigation Zhang Tongcun Professor CAR-T results transformation

On the morning of February 22, 2019, Zhou Zhihong, a member of the Organization Department of the Hubei Provincial Party Committee, and a group of 6 people came to Wuhan University of Science and Technology to investigate the transformation of scientific and technological achievements, and listened carefully to the chairman of Wuhan Bio-Raid Biotechnology Co., Ltd., Wuhan University of Science and Technology. Prof. Zhang Tongcun, Dean of the School of Life Science and Health, gave a special report on the transformation of CAR-T results. The meeting was hosted by Liu Jing, which is the Vice President of Wuhan University of Science and Technology.

2019

02-21

The National Development and Reform Commission High Technology Department visited our company

On February 20, 2019, Li Shuai, deputy researcher of the Second Division of the New Industry Division of the National Development and Reform Commission, and the representative of the Innovation Capacity Division visited the company for investigation and research, and highly praised the company's achievements in cancer treatment. Cai Li, Director of the High Technology Department of the Hubei Provincial Development and Reform Commission, and Feng Li, Chief Engineer of the Donghu High-tech Zone Management Committee, accompanied the delegation.
Bio-Raid

Wuhan Bio-Raid Biotechnology Co., Ltd.

 

Company address : 388 gaoxin 2nd road, east lake new technology development zone, wuhan city Floor 4, building 3, phase 3.1, wuhan optical valley international bio-pharmaceutical enterprise accelerator  Floor 5-1
Phone number :  086-027-59318269
E-mail：cart@bio-raid.com

 

Bio-Raid

Contact

© Wuhan Bio-Raid Biotechnology Co.,Ltd.  www.300.cn 鄂ICP备16000510号-1